Target intelligence / Profile preview

Eukaryotic translation initiation factor 2B subunit beta (EIF2B2)

Target
EIF2B2
Molecular classification
Enzyme (specifically, guanine nucleotide exchange factor), Translation factor (initiation factor), Intracellular protein complex subunit
01

Overview

Eukaryotic translation initiation factor 2B subunit beta (EIF2B2) is one of five subunits forming the eIF2B complex, a key regulator of protein synthesis initiation in eukaryotic cells. It acts as part of the regulatory core that modulates eIF2B's guanine nucleotide exchange factor (GEF) activity, specifically controlling exchange of GDP for GTP on the eIF2 complex, which is required for methionyl-initiator tRNA delivery to ribosomes. EIF2B2 and its associated complex play a central role in the integrated stress response, where regulation of protein synthesis allows cells to cope with physiological stress conditions. Mutations in EIF2B2 are a known cause of leukoencephalopathy with vanishing white matter, a severe neurological disorder marked by progressive breakdown of white matter in the brain. While the beta subunit itself is not currently a direct therapeutic target of approved drugs, its role in core translation and disease pathogenesis makes it a point of interest for research, especially in neurodegeneration and cancer.

Other names
Translation initiation factor eIF2B subunit betaEIF2B2EIF2BEIF-2BbetaEIF2BbetaS20I15S20III15eIF2B GDP-GTP exchange factor subunit betaVWM2Eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa
02

Mechanism of action

Modulation of GDP/GTP exchange activity on eIF2; Regulation of cellular response to stress via ISR pathway modulation; Restoration of protein synthesis via ISRIB or similar molecules (acts on eIF2B complex, not specifically beta subunit).

03

Biological functions

Regulation of protein synthesis (translation initiation)GDP–GTP exchange on eukaryotic initiation factor 2 (eIF2)Control of cellular response to stress (integrated stress response, ISR)Regulation of cellular proteostasis
04

Disease associations

Neurodegenerative disease (leukoencephalopathy with vanishing white matter, including ovarioleukodystrophy)Cancer, via altered regulation of translation and cell growthOther metabolic diseases involving proteostasis and translation dysregulation
05

Safety considerations

Targeting EIF2B2 could potentially disrupt global protein synthesis, leading to cellular dysfunctionMutations cause severe progressive neurological disorders—therapeutic modulation must consider risk of neurotoxicity and disturbance of cellular stress responsesHigh risk if therapeutic selectivity and tissue specific effect is not achieved
06

Interacting drugs

No specific approved drugs target EIF2B2 itself.

2 more in the full profile.

07

Biomarkers

Mutation detection in EIF2B2 gene for diagnosing vanishing white matter diseaseAltered protein synthesis rates or eIF2B-related gene expression may indicate cellular stress or cancer cell phenotypes

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2B subunit beta (EIF2B2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2B subunit beta (EIF2B2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call